TG THERAPEUTICS, INC. Interest Payable, Current
TG THERAPEUTICS, INC. (TGTX) had Interest Payable, Current of $0 as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2015-03-16
- 2014-12-31: Interest Payable, Current $0.00.
- 2014-09-30: Interest Payable, Current $0.00.
- 2014-06-30: Interest Payable, Current $0.00.
- 2014-03-31: Interest Payable, Current $0.00.
| Period end | Interest Payable, Current |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 |
| 2014-06-30 | $0.00 10-Q · filed 2014-07-24 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 |
| 2013-12-31 | $190.02K 10-K · filed 2015-03-16 |
| 2013-09-30 | $172.75K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $155.83K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $139.42K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $123.51K 10-K · filed 2014-03-07 |
| 2012-09-30 | $107.57K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $91.94K 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $76.79K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $61.94K 10-K · filed 2013-03-21 |
| 2011-09-30 | $47.22K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $160.06K 10-Q/A · filed 2011-09-14 |
| 2010-12-31 | $480.89K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |